Clinical trial
Effects of Targeted Temporal Interference Stimulation of Cerebellar Nuclei on Tremor and Gait Disturbance in Parkinson's Disease Patients
NCT07384442 is registered in ClinicalTrials.gov with YangPan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Targeted Temporal Interference Stimulation of Cerebellar Nuclei on Tremor and Gait Disturbance in Parkinson's Disease Patients
- Lead sponsor
- YangPan
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- August 19, 2026
- Completion date
- December 31, 2026
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
movement disorders, parkinson's disease